-
$AUPH: Cantor Fitzgerald reiterates overweight and raises PT to $16.#voclosporin AURORA may complete enrollment by 4Q18. -
$AUPH releases AURION topline data http://ir.auriniapharma.com/press-releases/detail/81 …#voclosporin -
Laying to rest certain ugly rumors about
$AUPH. New discussion at https://www.stockgumshoe.com/2017/12/dispelling-certain-aurinia-auph-rumors/comment-page-1/#comment-4964846 …#voclosporin -
#Anifrolumab#TULIP2,#belimumab#BLISSLN,#voclosporin#AURORA... and others that are coming. This is a great time (never thought) for#lupus treatment.https://twitter.com/NEJM/status/1207422788413227008 … -
Stephen Zaruby (CEO) and Neil Solomons (CMO) open up about what's in store for Aurinia
$AUPH. http://www.stockgumshoe.com/2015/08/an-auspicious-conversation-with-aurinia-ceo-stephen-zaruby/ …#Voclosporin -
Here at KidneyWeek2017. Exciting to see our data presented by others in the sessions here.
#lupusnephritis#KidneyWk17#voclosporin pic.twitter.com/oKzNnBzgE4
-
Churg-Strauss syndrome would be good candidate for Glickman's "other indication"
#voclosporin$AUPH -
"Couldnt be any better" ph3 results for
$AUPH + patent protection for#Voclosporin granted in the middle of 2019 = AUPH is a derisked asset for any BigPharma to gobble up for lupus nephritis. Buyout prices should be north of $30+ -
What a great day for
#lupus trials: positive phase 3 results for#voclosporin in lupus#nephritis Source:https://ir.auriniapharma.com/press-releases/detail/164/aurinia-announces-positive-aurora-phase-3-trial-results … -
@kidneydoc101 despite your positive feedback on$AUPH#voclosporin. There is a # of people who are bearish on the company and study design -
#Voclosporin meets 48-week remission endpoints, achieving highest CR of any global#LN study http://tinyurl.com/z2jo9on$AUPH#lupusnephritis -
Although LN isn't SLE, more evidence
$AUPH is on safe ground. https://www.fiercebiotech.com/biotech/as-sanofi-buyout-nears-ablynx-lupus-drug-flunks-midphase-trial?mkt_tok=eyJpIjoiT0RjeU1UY3dOVGczTldZMSIsInQiOiJmazlGbzFFUlRFWWp3ZHJiSDIwc2hWdG9HZ3ZBUlVXVTJ2UUVQSWt5cDl3dkVRRzRTdmlSSk5jWTFSMHMwN1BNbHpMYk5jUHVSTnZ4Vlh1cXg1Rm82RUlKb2crQ3FMTDloVFFXU25BWVdvbDlaRlhjbWdHUGw3bzZ3bSt0aWJCciJ9&mrkid=984926 … We've said for a while: mAb's are too specific, too narrow in target, to be good treatments for lupus-related conditions.#Voclosporin -
NEA Management owns
$AUPH as well. Maybe Scott Gottlieb will also grant AA for#Voclosporin.$GLYChttps://twitter.com/biosleuth/status/864144063162970113 … -
$AUPH and hold for Ph3 results or B/O. Barring unforeseen toxicity, at 40%+ CR,#Voclosporin will be utilized for treating LN patients. -
$AUPH to present late breaker poster session at National Kidney Foundation spring meeting on April 20#voclosporin https://ww3.aievolution.com/nkf1701/index.cfm?do=abs.viewAbs&abs=1487 … -
Facing questions on patient deaths,
$AUPH shares crater in wake of lupus study via@endpts#voclosporin#lupushttp://bit.ly/2bsPXig -
Results showed that renal response was achieved by 40.8% of
#voclosporin-treated#Lupusnephritis patients compared with 22.5% of the placebo group.
https://www.renalandurologynews.com/home/news/nephrology/lupus-nephritis/voclosporin-superior-to-standard-of-care-in-lupus-nephritis-trial/ … -
Check out the new
#AURORA study website#lupusnephritis#LN#lupus#SLE#voclosporin#clinicaltrial http://www.auroralnstudy.com/ -
Absolutely. Well done all but Brad you need to start using hashtags!!!
#lupus#nephritis#voclosporin#RCT#Aurora -
$AUPH Aurinia lupus candidate#voclosporin hits PhII target, but deaths send stock down http://www.fiercebiotech.com/node/455376 via@FierceBiotech
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.